europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

23/11/2022
PRESS RELEASE

Brussels, 23 November 2022

EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology. It had the aim to develop dialogue and momentum towards future thriving and competitive Europe through biotechnology innovation.

‘’The Healthcare BioForum was an outstanding opportunity to bring together our community and EU policymakers to  discuss how we can support European healthcare biotechnology sector. Our companies are working very hard to provide with excellent treatment European patients and we need to design the right environment for innovation to flourish. Only then the sector will thrive well, making Europe a leader of healthcare biotechnology in the world.’’, said Dr Claire Skentelbery, Director General of EuropaBio.

Open discussions revealed a common goal to make Europe a leader in healthcare biotechnology, starting with reinforcing dialogue and collaboration between industry and public actors, both at EU and national levels.

Key outcomes from the Healthcare BioForum

  • Europe needs a regulatory system fit for the 21st Century: efficient, flexible, and future proof
  • The EU’s legislative framework should ensure stability and predictability to attract investments
  • Europe’s scientific excellence can be translated into therapeutic innovation by supporting the biotechnology ecosystem
  • Europe should utilise the right tools and resources to ensure a competitive environment in the region
  • The EU innovation ecosystem should be fostered: From academia to startups, to established companies alike

EuropaBio’s inaugural Healthcare BioForum came at a critical time for Europe’s development towards a global centre of excellence, with benefits for patients and economies alike. It demonstrated that stakeholders have a shared vision for what Europe can, and should achieve. Innovators, policy makers, and facilitators can each bring their own expertise, perspective, and role. EuropaBio will help deliver the vision into reality across stakeholders for Europe, and the Healthcare BioForum establishes a long-term platform for open and forward-looking discussion. 

Read the full event report with recommendations HERE.

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022


Download

Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023


Read more
10/05/2023

#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee


Read more
09/05/2023

Dr Anne-Gaëlle Collot new Industrial Biotechnology Director at EuropaBio


Read more
26/04/2023

EuropaBio welcomes the publication of the revision of the EU Pharmaceutical Legislation


Read more

Important links

  • SwedenBIO joins EuropaBio: helping innovative companies succeed!
  • Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member